Does ERIBULIN Cause Metastasis? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Metastasis have been filed in association with ERIBULIN (eribulin mesylate). This represents 0.2% of all adverse event reports for ERIBULIN.
9
Reports of Metastasis with ERIBULIN
0.2%
of all ERIBULIN reports
1
Deaths
1
Hospitalizations
How Dangerous Is Metastasis From ERIBULIN?
Of the 9 reports, 1 (11.1%) resulted in death, 1 (11.1%) required hospitalization, and 2 (22.2%) were considered life-threatening.
Is Metastasis Listed in the Official Label?
Yes, Metastasis is listed as a known adverse reaction in the official FDA drug label for ERIBULIN.
What Other Side Effects Does ERIBULIN Cause?
Neutropenia (675)
Malignant neoplasm progression (594)
Myelosuppression (520)
Febrile neutropenia (448)
Neutrophil count decreased (294)
Neuropathy peripheral (290)
White blood cell count decreased (289)
Pyrexia (275)
Disease progression (211)
Fatigue (209)
What Other Drugs Cause Metastasis?
RIBOCICLIB (404)
LETROZOLE (284)
TRASTUZUMAB (273)
CYCLOPHOSPHAMIDE (267)
FULVESTRANT (262)
CAPECITABINE (233)
BEVACIZUMAB (225)
CARBOPLATIN (206)
LEUPROLIDE (201)
PACLITAXEL (198)
Which ERIBULIN Alternatives Have Lower Metastasis Risk?
ERIBULIN vs ERLOTINIB
ERIBULIN vs ERTAPENEM
ERIBULIN vs ERTUGLIFLOZIN PIDOLATE
ERIBULIN vs ERYTHROMYCIN
ERIBULIN vs ERYTHROMYCIN ETHYLSUCCINATE